Neutral impactCompany

Strides Pharma Science Limited — Analyst/Investor Meet Para A-XBRL

NSE 1 hr ago·23 Oct 2026, 2:58 pm
Strides Pharma SCI

Strides Pharma Science Limited has informed the Exchange about Schedule of Analysts or Institutional Investors Meet

Affected stocks

Neutral1 stock

Strides Pharma SCI

STAR Neutral

₹1,014.80

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

  • Concerns Strides Pharma SCI (STAR).
  • Category: Company.

Why it matters

A routine update for Strides Pharma SCI. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at NSE.

More Company news

More news
Company SEBI

Appeal No. 7099 of 2026 filed by Vikram Aggarwal

SEBI · 59 min ago

Panache Digilife

Panache Digilife Limited — Allotment of Securities

Panache Digilife₹652.70▲ 0.00%

NSE · 1 hr ago

Chennai Petroleum Corp LT

Chennai Petroleum Corporation Limited — Change in Directors/KMP/SMP/Auditor/RTA

Chennai Petroleum Corp LT₹1,475.60▲ 0.00%

NSE · 1 hr ago

Jindal Stainless

Jindal Stainless Limited — Analyst/Investor Meet Para A-XBRL

Jindal Stainless₹687.40▲ 0.00%

NSE · 1 hr ago

Nuvoco Vistas Corp

Nuvoco Vistas Corporation Limited — Analyst/Investor Meet Para A-XBRL

Nuvoco Vistas Corp₹330.60▲ 0.00%

NSE · 1 hr ago

Arisinfra Solutions

Arisinfra Solutions Limited — Notice Of Shareholders Meetings-XBRL

Arisinfra Solutions₹130.76▲ 0.00%

NSE · 1 hr ago

Unicommerce Esolutions L

Unicommerce Esolutions Limited — Change in Directors/KMP/SMP/Auditor/RTA

Unicommerce Esolutions L₹76.11▲ 0.00%

NSE · 1 hr ago

Company NSE

Rupeek Capital Private Limited — Intimation under Regulation 50(1)

NSE · 1 hr ago

Panache Digilife

Panache Digilife Limited — Outcome of Board Meeting

Panache Digilife₹652.70▲ 0.00%

NSE · 1 hr ago

Latest headlines

More news
Commodity RBI

Auction of State Government Securities

RBI · 59 min ago

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.